Renal Mass Biopsy Can Reduce Morbidity, Save Money
Routine renal mass biopsy for small renal masses can spare patients from having to undergo surgery and its associated complications and costs, according to a recent study.
Biopsy
Some Men With PI-RADS 5 Lesions Can Forgo Systematic Prostate Biopsy
Omitting systematic biopsy may reduce adverse events and complications.
MRI Can Avoid Unnecessary Prostate Biopsies Among Screened Men
In a trial of men who volunteered for PSA screening, detection of clinically insignificant tumors and benign findings were reduced when prostate biopsy was performed only in those with positive MRI results.
mpMRI Misses Few Significant Prostate Cancers in Re-Biopsied Men
Study findings lend support to using mpMRI for prostate cancer detection.
Noninvasive Markers Aid Risk Assessment of Prostate Cancer
Model combining measurement of EN2 protein marker and levels of 10 genes in urine could reduce unnecessary biopsies
Ureteroscopic Biopsy in UTUC May Increase Risk of Intravesical Recurrence
Compared with no ureteroscopy or percutaneous biopsy, ureteroscopic biopsy in patients with upper tract urothelial carcinoma was significantly associated with a 40% increased risk for intravesical recurrence of disease.
Transperineal MRI-TRUS Fusion Prostate Biopsy Safe Without Antibiotics
Less than 1% of patients who underwent the procedure under local analgesia and without antibiotic prophylaxis experienced post-biopsy infection, a study found.
Kidney Disease in SLE Possible Despite Low-Level Proteinuria
Based on new findings from a study of patients with systemic lupus erythematosus, investigators suggest revising current guidelines to expand kidney biopsy indications to include isolated proteinuria of any grade.
Biopsy Reclassification Risk in Prostate Cancer Examined
Gleason grade, prostate-specific antigen velocity, and imaging markers predict cancer spread.
Fewer Systematic Biopsy Cores May Not Lower PCa Detection Rate
In a study of patients undergoing transperineal prostate biopsy, the detection rate of clinically significant prostate cancer did not differ significantly between targeted biopsy (TB) with fewer systematic biopsy (SB) cores and TB with SB of the whole prostate.
- Loading...
Loading...
Next post in Prostate Cancer
Loading... 
Loading...